News tagged with novel compounds
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. ...
Cancer Apr 08, 2013 | not rated yet | 0
(Medical Xpress)—UC Irvine-led studies have revealed the cellular mechanism by which circadian rhythms – also known as the body clock – modify energy metabolism and also have identified novel compounds that control ...
Cardiology Jan 22, 2013 | 2 / 5 (2) | 0 |
A compound from the South African toothbrush tree inactivates a drug target for tuberculosis in a previously unseen way.
Diseases, Conditions, Syndromes Jan 14, 2013 | 5 / 5 (1) | 0 |
(Medical Xpress)—One of the world's top selling drugs potentially also acts against the growth of new lymphatic vessels, with potential implications for cancer therapy. This surprising finding was brought ...
Cancer Sep 04, 2012 | 5 / 5 (2) | 0 |
(Medical Xpress)—Scientists at the University of Liverpool and the Royal Liverpool University Hospital have been awarded £1.4 million to design a new drug for the treatment of chronic pain.
Medical research Aug 24, 2012 | not rated yet | 0
Researchers at the Hebrew University of Jerusalem have achieved, for the first time, the generation of neuronal cells from stem cells of Fragile X patients. The discovery paves the way for research that will examine restoration ...
Medical research May 22, 2012 | not rated yet | 0
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.
Medical research Sep 04, 2011 | 3.7 / 5 (3) | 0 |